126 related articles for article (PubMed ID: 26621819)
1. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
Schöller-Gyüre M; Kakuda TN; De Smedt G; Vanaken H; Bouche MP; Peeters M; Woodfall B; Hoetelmans RM
Br J Clin Pharmacol; 2008 Oct; 66(4):508-16. PubMed ID: 18492125
[TBL] [Abstract][Full Text] [Related]
3. Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
Egorin MJ; Shah DD; Christner SM; Yerk MA; Komazec KA; Appleman LR; Redner RL; Miller BM; Beumer JH
Br J Clin Pharmacol; 2009 Sep; 68(3):370-4. PubMed ID: 19740393
[TBL] [Abstract][Full Text] [Related]
4. Acid reflux directly causes sleep disturbances in rat with chronic esophagitis.
Nakahara K; Fujiwara Y; Tsukahara T; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Urade Y; Arakawa T
PLoS One; 2014; 9(9):e106969. PubMed ID: 25215524
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine.
Seng Yue C; Scarsi C; Bettazzi E; Mautone G; Celi FS; Ducharme M
Endocr Pract; 2024 Jun; 30(6):513-520. PubMed ID: 38554774
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.
Heilmann RM; Berghoff N; Grützner N; Parnell NK; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Nov; 13(1):321. PubMed ID: 29115998
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study.
Solomon DH; Diem SJ; Ruppert K; Lian YJ; Liu CC; Wohlfart A; Greendale GA; Finkelstein JS
J Bone Miner Res; 2015 Feb; 30(2):232-9. PubMed ID: 25156141
[TBL] [Abstract][Full Text] [Related]
8. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
[TBL] [Abstract][Full Text] [Related]
9. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.
Murofushi T; Yagi T; Tsuji D; Furushima D; Fujikura T; Itoh K; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4927-4938. PubMed ID: 38170305
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Freedberg DE; Toussaint NC; Chen SP; Ratner AJ; Whittier S; Wang TC; Wang HH; Abrams JA
Gastroenterology; 2015 Oct; 149(4):883-5.e9. PubMed ID: 26164495
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence.
Sawaid IO; Samson AO
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610738
[No Abstract] [Full Text] [Related]
12. Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signalling which is attenuated by proton pump inhibition.
Ghosh N; Kesh K; Singh PK; Sharma U; Chupikova I; Ramakrishnan S; Roy S
Br J Pharmacol; 2023 Jun; 180(12):1582-1596. PubMed ID: 36585367
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gastroprotectant administration in hospitalized cats in a tertiary referral hospital.
Ullal TV; Marks SL; Evenhuis JV; Figueroa ME; Pomerantz LK; Forsythe LR
J Feline Med Surg; 2023 Oct; 25(10):1098612X231201769. PubMed ID: 37874311
[TBL] [Abstract][Full Text] [Related]
14. Indication of acid suppression therapy and predictors for the prophylactic use of protonpump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital.
Oh AL; Tan AG; Phan HS; Lee BC; Jumaat N; Chew SP; Wong SH; Ting SH; Subramaniam T
Pharm Pract (Granada); 2015; 13(3):633. PubMed ID: 26445624
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and appropriateness of omeprazole prescription in dogs at a veterinary teaching hospital before and after the publication of the ACVIM consensus statement on the rational administration of gastrointestinal protectants.
Sainz Á; García-Sancho M; Villaescusa A; Rodríguez-Franco F; Díaz-Regañón D; Olmeda P; Marks SL
Front Vet Sci; 2024; 11():1352496. PubMed ID: 38774912
[TBL] [Abstract][Full Text] [Related]
16. The effect of ranitidine on cellular immunity in patients with multiple myeloma.
Nielsen HJ; Nielsen H; Moesgaard F; Tvede N; Klarlund K; Mansa B; Drivsholm A
Cancer Immunol Immunother; 1990; 32(3):201-5. PubMed ID: 2289214
[TBL] [Abstract][Full Text] [Related]
17. Do the omeprazole family compounds exert a protective effect against influenza-like illness?
Gasparini R; Lai PL; Casabona F; Trucchi C; Boccalini S; Cristina ML; Rossi S; Amicizia D; Panatto D
BMC Infect Dis; 2014 Jun; 14():297. PubMed ID: 24889553
[TBL] [Abstract][Full Text] [Related]
18. Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing.
McRorie JW; Kirby JA; Miner PB
World J Gastrointest Pharmacol Ther; 2014 May; 5(2):57-62. PubMed ID: 24868486
[TBL] [Abstract][Full Text] [Related]
19. The Association between Ranitidine Use and Gastrointestinal Cancers.
McGwin G
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374592
[TBL] [Abstract][Full Text] [Related]
20. Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?
Safe M; Chan WH; Leach ST; Sutton L; Lui K; Krishnan U
World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):531-539. PubMed ID: 27867686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
